Malsy, Manuela and Gebhardt, Kristina and Gruber, Michael and Wiese, Christoph and Graf, Bernhard and Bundscherer, Anika (2015) Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells. BMC ANESTHESIOLOGY, 15. ISSN 1471-2253,
Full text not available from this repository. (Request a copy)Abstract
Background: Adenocarcinoma of the pancreas is one of the most aggressive cancer diseases affecting the human body. The oncogenic potential of this type of cancer is mainly characterized by its extreme growth rate triggered by the activation of signaling cascades. Modern oncological treatment strategies aim at efficiently modulating specific signaling and transcriptional pathways. Recently, anti-tumoral potential has been proven for several substances that are not primarily used in cancer treatment. In some tumor entities, for example, administration of glutamate antagonists inhibits cell proliferation, cell cycle arrest, and finally cell death. To attain endogenic proof of NMDA receptor type expression in the pancreatic cancer cell lines PaTu8988t and Panc-1 and to investigate the impact of ketamine, s-ketamine, and the NMDA receptor antagonist MK 801 on proliferation, apoptosis, and necrosis in pancreatic carcinoma. Methods: Cell proliferation was measured by means of the ELISA BrdU assay, and the apoptosis rate was analyzed by annexin V staining. Immunoblotting were also used. Results: The NMDA receptor type R2a was expressed in both pancreatic carcinoma cell lines. Furthermore, ketamine, s-ketamine, and MK 801 significantly inhibited proliferation and apoptosis. Conclusions: In this study, we showed the expression of the NMDA receptor type R2a in pancreatic cancer cells. The NMDA antagonists ketamine, s-ketamine, and MK 801 inhibited cell proliferation and cell death. Further clinical studies are warranted to identify the impact of these agents on the treatment of cancer patients.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | D-ASPARTATE RECEPTOR; PROSTATE-CANCER; TUMOR-GROWTH; PATHWAY; ANTAGONISTS; PROPOFOL; SURGERY; PAIN; Ketamine; S-ketamine; MK 801; Proliferation; Apoptosis; Necrosis; NMDA; Pancreatic carcinoma; Cancer |
Subjects: | 600 Technology > 610 Medical sciences Medicine |
Divisions: | Medicine > Lehrstuhl für Anästhesiologie |
Depositing User: | Dr. Gernot Deinzer |
Date Deposited: | 05 Jul 2019 12:18 |
Last Modified: | 05 Jul 2019 12:18 |
URI: | https://pred.uni-regensburg.de/id/eprint/5180 |
Actions (login required)
View Item |